Skip to content

A Culturally-tailored Personalized Nutrition Intervention in South Asian Women at Risk of Gestational Diabetes

A Culturally-tailored Personalized Nutrition Intervention in South Asian Women at Risk of Gestational Diabetes Mellitus

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03607799
Acronym
DESI-GDM
Enrollment
140
Registered
2018-07-31
Start date
2020-11-26
Completion date
2025-12-31
Last updated
2025-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Gestational

Keywords

South Asian, diet

Brief summary

This trial will assess the impact of a culturally tailored, personalized nutrition intervention on glycemic response to an oral glucose load (as measured by the area-under-the curve glucose) in high-risk pregnancies of South Asian women. The intervention targets two at-risk individuals: mother and infant, breaking the cycle of maternal gestational dysglycemia, excess infant adiposity and insulin resistance, and CVD in both mother and baby. The findings of this study will be important in guiding future evidence-based recommendations and public health policies to manage gestational glycemia in pregnant women at risk of GDM.

Detailed description

The DESI-GDM study is a randomized study to assess the impact of a culturally tailored, personalized nutrition intervention on glycemic response to an oral glucose load in high-risk pregnancies of South Asian women. Eligible South Asian pregnant women will be randomized to intervention or control. South Asians (SA), people whose ancestors are from India, Pakistan, Bangladesh, or Sri Lanka, are the largest non-white ethnic group in Canada, and are at high risk of type 2 diabetes mellitus (T2DM) and early cardiovascular disease (CVD). SA women have at least double the risk of gestational diabetes (GDM) of white European women, and risk factors for future T2DM in the offspring including higher birthweight, more adipose tissue, and reduced insulin sensitivity, are more common in SA infants of mothers with GDM than infants born to mothers without GDM. Building on our findings from the South Asian prospective birth cohort (START), which identified diet as a key modifiable risk factor for GDM, we have developed a dietary intervention. The women we spoke with expressed a desire to learn more about healthy eating to prevent diabetes during pregnancy and were keen to use mobile health technology. The objectives of this trial among pregnant women of South Asian descent are to: 1. Evaluate the effectiveness of a culturally-tailored personalized nutrition intervention delivered by a trained health coach to improve blood sugar levels in South Asian women to a greater extant than usual dietary advice. 2. Evaluate the effectiveness of a culturally-tailored personalized nutrition intervention delivered by a trained health coach to pregnant South Asian women in the reduction of the incidence of gestational diabetes mellitus to a greater extent than usual dietary advice. The findings of this study will be important in guiding future evidence-based recommendations and public health policies to manage gestational glycemia in pregnant women at risk of GDM.

Interventions

BEHAVIORALDietary Intervention

Individualized diet advice will be developed for each participant by a dietitian familiar with South Asian foods.

BEHAVIORALControl

Control group participants will be provided with PDFs, website links to encourage healthy eating, physical activity, and other lifestyle factors during pregnancy. They will also receive weekly text messages aimed at increasing walking.

Sponsors

Hamilton Health Sciences Corporation
CollaboratorOTHER
Population Health Research Institute
CollaboratorOTHER
McMaster University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Masking description

Those assessing the primary and secondary clinical outcomes are masked to treatment assignment.

Intervention model description

Human

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* pregnant * South Asian ancestry * gestational week 12-18 * singleton pregnancy * at least 2 of the following: 1. age \> 29 2. low diet quality (assessed with a short diet questionnaire) 3. family history of type 2 diabetes in first-degree relative 4. gestational diabetes during a previous pregnancy 5. pre-pregnancy body-mass-index ≥23.17

Exclusion criteria

* type 1 or type 2 diabetes * high blood pressure (\>140 mm Hg systolic or \>90 mm Hg diastolic) * poor understanding of English * unwillingness to modify diet * at high risk of adverse pregnancy outcomes other than gestational diabetes (e.g. twins or higher-order multiples, use of fertility treatment(s), pre-existing hypertension, history of placenta previa or pre-term birth) * enrollment in another study * does not have a smartphone * not willing to walk * excessive nausea and/or vomiting

Design outcomes

Primary

MeasureTime frameDescription
Glucose area-under-the-curve (glucose AUC)3 monthsA measure of glycemic response, glucose AUC is a continuous measure of the response to a 75-g oral glucose tolerance test, and is calculated by the trapezoidal method using the fasting, 1-h, and 2-h glucose.

Secondary

MeasureTime frameDescription
Gestational diabetes mellitus3 monthsGestational diabetes mellitus is classified using the cut-offs derived in a large cohort of South Asian women from the Born in Bradford: fasting glucose level \>= 5.2 mmol/L, or 2-hour post-load level \>=7.2 mmol/L.

Other

MeasureTime frameDescription
Maternal blood pressure3 monthsWe measure maternal blood pressure at baseline and the OGTT visit.
Maternal pregnancy complications3 monthsPregnancy complications will be noted at coaching contacts.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026